This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duvillié, B. Articles by Hill, D. J. Search for Related Content PubMed PubMed Citation Articles by Duvillié, B. Articles by Hill, D. J.

Increased Islet Cell Proliferation, Decreased Apoptosis, and Greater Vascularization Leading to ß-Cell Hyperplasia in Mutant Mice Lacking Insulin

Medical Research Council Group in Fetal and Neonatal Health and Development (B.D., C.C., T.C., D.J.H.), Lawson Health Research Institute, London, Ontario, Canada N6A4V2; Departments of Physiology, Medicine, and Paediatrics (D.J.H.), University of Western Ontario, London, Ontario, Canada N6A 5A5; and U257 Institut National de la Santé et de la Recherche Médicale (D.B., J.J., R.L.J.), 75014 Paris, France

Address all correspondence and requests for reprints to: Dr. Bertrand Duvillié, U457 Institut National de la Santé et de la Recherche Médicale, Hôpital R. Debré, 48 Bd Serrurier, 75019 Paris, France.

The targeted disruption of the two nonallelic insulin genes in mouse was reported previously to result in intrauterine growth retardation, severe diabetes immediately after suckling, and death within 48 h of birth. We have further used these animals to investigate the morphology and cell biology of the endocrine pancreas in late gestation and at birth when insulin is absent throughout development. Pancreatic ß-cells were identified by detecting the activity of the LacZ gene inserted at the Ins2 locus. A significant increase in the mean area of the islets was found at embryonic d 18.5 (E18.5) and in the newborn in Ins1-/-, Ins2-/- animals compared with Ins1-/-, Ins2+/- and wild-type controls, whereas the blood glucose levels were unaltered. The individual size of the ß-cells in the insulin-deficient fetuses was similar to controls, suggesting that the relative increase in islet size was due to an increase in cell number. Immunohistochemistry for proliferating cell nuclear antigen within the pancreatic ductal epithelium showed no differences in labeling index between insulin-deficient and control mice, and no change in the number of ß-cells associated with ducts, but the relative size distribution of the islets was altered so that fewer islets under 5,000 µm² and more islets greater than 10,000 µm² were present in Ins1-/-, Ins2-/- animals. This suggests that the greater mean islet size seen in insulin-deficient animals represented an enlargement of formed islets and was not associated with an increase in islet neogenesis. The proportional contribution of - and ß-cells to the islets was not altered. This was supported by an increase in the number of cells containing immunoreactive proliferating cell nuclear antigen in both islet - and ß-cells at E18.5 in insulin-deficient mice, and a significantly lower incidence of apoptotic cells, as determined by molecular histochemistry using the terminal deoxynucleotidyl transferase-mediated deoxy-UTP nick end labeling reaction. The density of blood vessels within sections of whole pancreas, or within islets, was determined by immunohistochemistry for the endothelial cell marker CD31 and was found to be increased 2-fold in insulin-deficient mice compared with controls at E18.5. However, no changes were found in the steady-state expression of mRNAs encoding vascular endothelial growth factor, its receptor Flk-1, IGF-I or -II, the IGF-I and insulin receptors, or insulin receptor substrates-1 or -2 in pancreata from Ins1-/-, Ins2-/- mice compared with Ins1-/-, Ins2+/- controls. Thus, we conclude that the relative hyperplasia of the islets in late gestation in the insulin-deficient mice was due to an increased islet cell proliferation coupled with a reduced apoptosis, which may be related to an increased vascularization of the pancreas.

This article has been cited by other articles:

				J. L. Beith, E. U. Alejandro, and J. D. Johnson Insulin Stimulates Primary {beta}-Cell Proliferation via Raf-1 Kinase Endocrinology, May 1, 2008; 149(5): 2251 - 2260. [Abstract] [Full Text] [PDF]

				J. Jiang, M. Au, K. Lu, A. Eshpeter, G. Korbutt, G. Fisk, and A. S. Majumdar Generation of Insulin-Producing Islet-Like Clusters from Human Embryonic Stem Cells Stem Cells, August 1, 2007; 25(8): 1940 - 1953. [Abstract] [Full Text] [PDF]

				T. Okada, C. W. Liew, J. Hu, C. Hinault, M. D. Michael, J. Krtzfeldt, C. Yin, M. Holzenberger, M. Stoffel, and R. N. Kulkarni From the Cover: Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance PNAS, May 22, 2007; 104(21): 8977 - 8982. [Abstract] [Full Text] [PDF]

				C. E. Gleason, D. N. Gross, and M. J. Birnbaum When the usual insulin is just not enough PNAS, May 22, 2007; 104(21): 8681 - 8682. [Full Text] [PDF]

				N. Herbach, B. Rathkolb, E. Kemter, L. Pichl, M. Klaften, M. H. de Angelis, P. A. Halban, E. Wolf, B. Aigner, and R. Wanke Dominant-Negative Effects of a Novel Mutated Ins2 Allele Causes Early-Onset Diabetes and Severe {beta}-Cell Loss in Munich Ins2C95S Mutant Mice Diabetes, May 1, 2007; 56(5): 1268 - 1276. [Abstract] [Full Text] [PDF]

				P. M. Vuguin, M. H. Kedees, L. Cui, Y. Guz, R. W. Gelling, M. Nejathaim, M. J. Charron, and G. Teitelman Ablation of the Glucagon Receptor Gene Increases Fetal Lethality and Produces Alterations in Islet Development and Maturation Endocrinology, September 1, 2006; 147(9): 3995 - 4006. [Abstract] [Full Text] [PDF]

				A. S. Narang and R. I. Mahato Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243. [Abstract] [Full Text] [PDF]

				M. Daimon, G. Ji, T. Oizumi, T. Kido, M. Baba, Y. Jimbu, W. Kameda, S. Susa, H. Yamaguchi, H. Ohnuma, et al. Association of Nephrin Gene Polymorphisms With Type 2 Diabetes in a Japanese Population: The Funagata Study Diabetes Care, May 1, 2006; 29(5): 1117 - 1119. [Full Text] [PDF]

				M. Johansson, G. Mattsson, A. Andersson, L. Jansson, and P.-O. Carlsson Islet Endothelial Cells and Pancreatic {beta}-Cell Proliferation: Studies in Vitro and during Pregnancy in Adult Rats Endocrinology, May 1, 2006; 147(5): 2315 - 2324. [Abstract] [Full Text] [PDF]

				M. Ejrnaes, N. Videbaek, U. Christen, A. Cooke, B. K. Michelsen, and M. von Herrath Different Diabetogenic Potential of Autoaggressive CD8+ Clones Associated with IFN-{gamma}-Inducible Protein 10 (CXC Chemokine Ligand 10) Production but Not Cytokine Expression, Cytolytic Activity, or Homing Characteristics J. Immunol., March 1, 2005; 174(5): 2746 - 2755. [Abstract] [Full Text] [PDF]

				M. K. Treutelaar, J. M. Skidmore, C. L. Dias-Leme, M. Hara, L. Zhang, D. Simeone, D. M. Martin, and C. F. Burant Nestin-Lineage Cells Contribute to the Microvasculature but Not Endocrine Cells of the Islet Diabetes, October 1, 2003; 52(10): 2503 - 2512. [Abstract] [Full Text] [PDF]

				M. Vincent, Y. Guz, M. Rozenberg, G. Webb, M. Furuta, D. Steiner, and G. Teitelman Abrogation of Protein Convertase 2 Activity Results in Delayed Islet Cell Differentiation and Maturation, Increased {alpha}-Cell Proliferation, and Islet Neogenesis Endocrinology, September 1, 2003; 144(9): 4061 - 4069. [Abstract] [Full Text] [PDF]